The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Araujo, J. A.
Right arrow Articles by Kupiec-Weglinski, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Araujo, J. A.
Right arrow Articles by Kupiec-Weglinski, J. W.
The Journal of Immunology, 2003, 171: 1572-1580.
Copyright © 2003 by The American Association of Immunologists

Systemic Rather Than Local Heme Oxygenase-1 Overexpression Improves Cardiac Allograft Outcomes in a New Transgenic Mouse1

Jesus A. Araujo2,*,{dagger}, Lingzhong Meng2,{ddagger}, Aaron D. Tward3,*, Wayne W. Hancock§, Yuan Zhai{ddagger}, Annie Lee*, Kazunobu Ishikawa4,*, Suhasini Iyer, Roland Buelow, Ronald W. Busuttil{ddagger}, Diana M. Shih*, Aldons J. Lusis*,{dagger} and Jerzy W. Kupiec-Weglinski5,{ddagger}

* Division of Cardiology, {dagger} Molecular Biology Institute, and {ddagger} Dumont-University of California, Los Angeles Transplant Center, Department of Surgery and Pathology, University of California, Los Angeles, CA 90095; § Biesecker Center and Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA 19104; and SangStat Medical Corporation, Fremont, CA 94555

Heme oxygenase-1 (HO-1), a rate-limiting enzyme in heme catabolism, exhibits potent antioxidant and anti-inflammatory properties. We developed HO-1 transgenic (Tg) mice using a rat HO-1 genomic transgene under the control of the endogenous promoter. Transgene expression was demonstrated by RT-PCR in all studied tissues, and a modest HO-1 overexpression was documented by Western, ELISA, and enzyme activity assays. To assess the effect of local vs systemic HO-1 in the acute rejection response, we used Tg mice as organ donors or recipients of MHC-incompatible heart grafts. In the local HO-1 overexpression model, Tg allografts survived 10.5 ± 0.7 days (n = 10), compared with 6.5 ± 0.4 days (n = 6) for wild-type donor controls (p = 0.0001). In the systemic HO-1 overexpression model, Tg recipients maintained allografts for 26.8 ± 3.4 days (n = 10), compared with 6.3 ± 0.1 days (n = 12) in wild-type controls (p = 0.00009). Inhibition of HO activity by treatment with tin protoporphyrin blunted survival advantage in Tg mice and resulted in acute graft rejection (n = 3). Increased carboxyhemoglobin levels were consistently noted in Tg mice. Comparisons of grafts at day 4 indicated that HO-1 overexpression was inversely associated with vasculitis/inflammatory cell infiltrate in both models. Hearts transplanted into Tg recipients showed decreased CD4+ lymphocyte infiltration and diminished immune activation, as judged by CD25 expression. Thus, although local and systemic HO-1 overexpression improved allograft outcomes, systemic HO-1 led to a more robust protection and resulted in a significant blunting of host immune activation. This Tg mouse provides a valuable tool to study mechanisms by which HO-1 exerts beneficial effects in organ transplantation.




This article has been cited by other articles:


Home page
FASEB J.Home page
A. Goldberg, M. Parolini, B. Y. Chin, E. Czismadia, L. E. Otterbein, F. H. Bach, and H. Wang
Toll-like receptor 4 suppression leads to islet allograft survival
FASEB J, September 1, 2007; 21(11): 2840 - 2848.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. D. Orozco, M. H. Kapturczak, B. Barajas, X. Wang, M. M. Weinstein, J. Wong, J. Deshane, S. Bolisetty, Z. Shaposhnik, D. M. Shih, et al.
Heme Oxygenase-1 Expression in Macrophages Plays a Beneficial Role in Atherosclerosis
Circ. Res., June 22, 2007; 100(12): 1703 - 1711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-H. Woo, M. P. Massett, T. Shishido, S. Itoh, B. Ding, C. McClain, W. Che, S. R. Vulapalli, C. Yan, and J.-i. Abe
ERK5 Activation Inhibits Inflammatory Responses via Peroxisome Proliferator-activated Receptor {delta} (PPAR{delta}) Stimulation
J. Biol. Chem., October 27, 2006; 281(43): 32164 - 32174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Sacerdoti, M. Bolognesi, M. Di Pascoli, A. Gatta, J. C. McGiff, M. L. Schwartzman, and N. G. Abraham
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1999 - H2002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. P. Juncos, J. P. Grande, N. Murali, A. J. Croatt, L. A. Juncos, R. P. Hebbel, Z. S. Katusic, and K. A. Nath
Anomalous Renal Effects of Tin Protoporphyrin in a Murine Model of Sickle Cell Disease
Am. J. Pathol., July 1, 2006; 169(1): 21 - 31.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Li, E. Simeoni, S. Fleury, J. Dudler, E. Fiorini, L. Kappenberger, L. K. von Segesser, and G. Vassalli
Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 779 - 783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. S. Neto, A. Nakao, H. Toyokawa, M. A. Nalesnik, A. J. Romanosky, K. Kimizuka, T. Kaizu, N. Hashimoto, O. Azhipa, D. B. Stolz, et al.
Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy
Am J Physiol Renal Physiol, February 1, 2006; 290(2): F324 - F334.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Laxmanan, D. Datta, C. Geehan, D. M. Briscoe, and S. Pal
CD40: A Mediator of Pro- and Anti-Inflammatory Signals in Renal Tubular Epithelial Cells
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2714 - 2723.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Chauveau, S. Remy, P. J. Royer, M. Hill, S. Tanguy-Royer, F.-X. Hubert, L. Tesson, R. Brion, G. Beriou, M. Gregoire, et al.
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression
Blood, September 1, 2005; 106(5): 1694 - 1702.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Chen, M. H. Kapturczak, C. Wasserfall, O. Y. Glushakova, M. Campbell-Thompson, J. S. Deshane, R. Joseph, P. E. Cruz, W. W. Hauswirth, K. M. Madsen, et al.
Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway
PNAS, May 17, 2005; 102(20): 7251 - 7256.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Wang, S. S. Lee, W. Gao, E. Czismadia, J. McDaid, R. Ollinger, M. P. Soares, K. Yamashita, and F. H. Bach
Donor Treatment With Carbon Monoxide Can Yield Islet Allograft Survival and Tolerance
Diabetes, May 1, 2005; 54(5): 1400 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kawamura, K. Ishikawa, Y. Wada, S. Kimura, H. Matsumoto, T. Kohro, H. Itabe, T. Kodama, and Y. Maruyama
Bilirubin From Heme Oxygenase-1 Attenuates Vascular Endothelial Activation and Dysfunction
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 155 - 160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-O. Pae, G.-S. Oh, B.-M. Choi, S.-C. Chae, Y.-M. Kim, K.-R. Chung, and H.-T. Chung
Carbon Monoxide Produced by Heme Oxygenase-1 Suppresses T Cell Proliferation via Inhibition of IL-2 Production
J. Immunol., April 15, 2004; 172(8): 4744 - 4751.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.